MonserratArroyo (@DraMonserrat) profile picture

Neumóloga y Somnóloga en CDMX

Joined April 2019
Photo by MonserratArroyo (@DraMonserrat)Photo by MonserratArroyo (@DraMonserrat)Photo by MonserratArroyo (@DraMonserrat)Photo by MonserratArroyo (@DraMonserrat)
MonserratArroyo retweeted
This articles summarises recommendations on asthma diagnosis, monitoring, and chronic management. This #BMJInfographic outlines new management pathways for people aged 5 years and older bmj.com/content/390/bmj.r116…
1
27
3
53
13,194
Today is World Asthma Day! GINA emphasizes the need to empower people with asthma with the appropriate education to manage their disease - Asthma Education Empowers. Download the new 2024 report here: ginasthma.org/2024-report/ #WorldAsthmaDay #GINA #Asthma #AsthmaEducation
105
11
155
12,807
MonserratArroyo retweeted
#WorldSleepDay #DiaMundialdelsueño Feliz Día Mundial del Sueño
1
6
1
11
1,281
Definition of Clinical #Remission in #Asthma on Treatment: a consensus from @atscommunity @ACAAI @AAAAI_org @wheezemd @EFornoMD @simcouillard @emschaub annallergy.org/article/S1081…
4
20
43
4,761
New 2023 GINA Severe asthma booklet is available for personal download. Printed copies will soon be available to buy. Please share this: ginasthma.org/severeasthma/
1
302
17
540
63,287
MonserratArroyo retweeted
Randomised controlled trial for the titration of oral corticosteroids using markers of inflammation in severe asthma thorax.bmj.com/content/78/9/… @jlgiffo, @nessmcd, @PeterWark1710
1
11
1
16
2,908
MonserratArroyo retweeted
🌏Respirology Don't miss our latest Letter from the #AsiaPacific and Beyond with the Letter from #Mexico: A 2023 #postCOVID update onlinelibrary.wiley.com/doi/…
5
16
1,895
Management of asthma - the importance of peak expiratory flow (PEF) monitoring: In those with confirmed asthma, peak expiratory flow (PEF) or FEV1 are useful and valid measures of airway calibre. PEF is more convenient in the acute situation.#WorldAsthmaDay2023
1
10
1
17
3,831
Replying to @JACIInPractice
@JACIInPractice Baseline #FeNO Predicts #Dupilumab Response in Patients With Moderate/Severe #Asthma independently of #eosinophil levels and other clinical characteristics. jaci-inpractice.org/action/s… #asma @ginasthma @ALAT_Asma @AsmaSEPAR @gemasma @asthma_papers
4
4
572
MonserratArroyo retweeted
Eres médico, decidiste hacer una especialidad. Aunque vas por la vida predicando que el dinero no importa, en el fondo sabes que sí; mucha presión social de por medio. Terminaste tu preparación a los 35 años, con dos especialidades y una alta especialidad.
62
976
172
4,812
541,544
A review of different types of sleep disordered breathing and available screening methods in pre-operative assessment, as well as peri-operative management strategies https://nitter.cf/t.co/YPwR7w4JkP
#SleepApnea occurs in about 1/2 of people with #heartfailure or #AFib and 1/3 of people with #hypertension and #CoronaryArteryDisease. Download our #CardioSmart infographic on sleep apnea: https://nitter.cf/t.co/OI8ZfOiZnt #ACCMiddleEast
1
11
1
30
MonserratArroyo retweeted
1/ 🗂Este documento publicado en @ArchBronconeumo no es un paper cualquiera. Es el DOCUMENTO INTERNACIONAL DE CONSENSO (DIC) SOBRE #APNEA OBSTRUCTIVA DEL #SUEÑO 🌍😴 Le he dedicado dos años de trabajo y por eso merece un 🧵y agradezco RT 🙏🏻
11
231
6
345
MonserratArroyo retweeted
If you are fully vaccinated against #COVID19, you can start doing some things again, like gathering indoors with other fully vaccinated people without wearing masks. Learn more: https://nitter.cf/t.co/TRZRzx3cym.
37
129
7
228
Nos mantenemos saturados pacientes en sala de espera y camillas al tope, lista de espera para acceso a UCI. #COVID19 TOMEN PRECAUCIONES POR FAVOR !!
29
514
62
860
MonserratArroyo retweeted
Score de predicción de gravedad en COVID19 validada con parámetros sencillos. Ello sugiere posible manejo ambulatorio en menor riesgo, y en puntajes ≥9 tratamiento agresivo y monitorización intensa. Calculadora en línea está disponible en isaric4c.net/risk/.
4
2
MonserratArroyo retweeted
INFORMACION PARA PACIENTES CON ASMA ANTE COVID-19 Asma es una enfermedad frecuente que afecta alrededor de 6 millones de personas en México por lo que ante la pandemia de COVID-19 (SARS-CoV-2) es importante hacer algunas consideraciones:
17
438
37
433